Results 191 to 200 of about 1,272,650 (214)

Crosstalk between purinergic receptor P2Y₁₁ and chemokine receptor CXCR7 is regulated by CXCR4 in human macrophages. [PDF]

Cell Mol Life Sci
Klaver D, Gander H, Frena B, Amato M, Thurnher M.   +4 more
europepmc   +1 more source

Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism. [PDF]

Channels (Austin)
Al-Aqtash R, Collier DM.
europepmc   +1 more source

[<i>Clostridium perfringens</i> Beta1 toxin induces macrophage pyroptosis and ferroptosis through the purinergic receptor P2X7-Ca²⁺ axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang S, Ran L, Zeng J, Wang Y.
europepmc   +1 more source

Distribution of P2Y and P2X purinergic receptor expression within the intestine.

Am J Physiol Gastrointest Liver Physiol
Engevik KA, Scribano FJ, Gebert JT, Perry JL, Crawford SE, Hyser JM.   +5 more
europepmc   +1 more source

Radioligands targeting purinergic P2X7 receptor

Bioorganic and Medicinal Chemistry Letters, 2020
The purinergic P2X7 receptor (P2X7R) is an adenosine triphosphate (ATP) ligand-gated cationic channel receptor. P2X7R is closely associated with various inflammatory, immune, cancer, neurological, musculoskeletal and cardiovascular disorders. P2X7R is an

exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor

Current Medicinal Chemistry, 2023
Youngjoo Byun, Jaebong Jang
exaly  

Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension

International Journal of Environmental Research and Public Health, 2021
Tatyana Novoyatleva, Ralph Schermuly, Akylbek Sydykov   +2 more
exaly  

Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis

International Journal of Molecular Sciences, 2022
Elisabetta Bolognesi, Mario Clerici, Franca Rosa Guerini   +2 more
exaly  

The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?

International Journal of Molecular Sciences, 2021
Thomas Gicquel, Brendan le Dare, Pierre-Jean Ferron   +2 more
exaly